26 October 2022 鈥� To help pharmaceutical brands deliver faster-to-market nasal spray solutions, Silgan Dispensing, a global leader in the design, development and distribution of highly engineered pumps and sprayers in the pharmaceutical, home and beauty markets, announces the launch of the Gemini鈩� BE Nasal Pump.
Developed with Silgan Dispensing鈥檚 Bioequivalence (BE) Program, the Gemini鈩� BE Nasal Pump is adaptable to effectively match specific formulations for a perfect performance fit and quick time-to-market. With an extensive five-stage custom process, Gemini鈩� allows for ultimate customisability with over 40 different spray configurations.
Additional benefits of the Gemini鈩� BE Nasal Pump include:
- Cleanroom, pharma-grade, and ISO-certified production
- High-dosing accuracy
- Low strokes to prime
- Capability to match existing reference listed drug (RLD) devices across a range of formulations
- Ability to modify spray characteristics like DSD, plume geometry, and spray pattern
鈥淏ioequivalence testing helps our customers overcome regulatory and technical barriers that have previously slowed product commercialisation,鈥� said Allan Houston, vice-president of healthcare sales and marketing at Silgan Dispensing. 鈥淭he Gemini鈩� BE Nasal Pump showcases our BE Program and Silgan Dispensing鈥檚 ability to deliver expedited nasal devices that fit our customers鈥� needs as a replacement or secondary supply chain option.鈥�
Silgan Dispensing鈥檚 BE Program is aligned with US FDA and EU methods 鈥� providing customers the confidence they require from a healthcare packaging supplier. Additionally, the BE Program is supported by Silgan Dispensing鈥檚 regulatory team, utilising the company鈥檚 Nasal Spray Testing cGMP lab and equipment, and partners with accredited, external cGMP lab testing services and CMOs for nasal products.
Attendees and media are invited to get a firsthand look at the Gemini鈩� BE Nasal pump at Booth 30A80 in Hall 3.0.
For more information about Gemini鈩� BE Nasal Pump, please visit .